Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
179.33
-0.03 (-0.02%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.76B in the quarter ending June 30, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $10.52B, up 12.58% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.52B
Revenue Growth
+12.58%
P/S Ratio
1.90
Revenue / Employee
$187,893
Employees
56,000
Market Cap
20.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DGX News
- 5 days ago - Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript - Seeking Alpha
- 10 days ago - Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 - PRNewsWire
- 11 days ago - Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States - Business Wire
- 12 days ago - Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration - PRNewsWire
- 13 days ago - Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer - PRNewsWire
- 17 days ago - WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App - Business Wire
- 19 days ago - Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference - PRNewsWire
- 25 days ago - Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha